Transforming modern infectious disease surveillance and outbreak response

NGS offers powerful and comprehensive solutions for infectious disease detection and characterization

NGS for Infectious Diseases

Genomics is transforming modern infectious disease surveillance, expanding our understanding of pathogen evolution, host–pathogen interactions, and antibiotic resistance. In turn, public health professionals are changing the methods they use to research, monitor, and prevent epidemics and pandemics of high-profile infectious diseases such as influenza, tuberculosis, Ebola, and more recently, coronavirus.

Traditional methods of assessing infectious agents include antibody-based testing, real-time PCR, pulsed field gel electrophoresis, and multilocus sequence typing. These methods are typically useful only for a small and defined number of organisms, and data analysis can be subjective. In contrast, next-generation sequencing (NGS) provides a universal, hypothesis-free method for infectious disease surveillance that may be used with viruses, bacteria, fungi, or parasites, and can replace the need for multiple tests. 

Human Microbiome Analysis
COVID-19 Solutions

Next-generation sequencing is uniquely positioned in an infectious disease surveillance and outbreak model. Compare NGS methods and find solutions to detect and characterize SARS-CoV2, track transmission routes, study co-infection, and investigate viral evolution. 

Learn More
Illumina Perspective on the Novel Coronavirus SARS-CoV-2 Outbreak

Find and Characterize Respiratory Viruses with Illumina RNA Prep with Enrichment

A rapid target enrichment sequencing workflow for highly sensitive detection and characterization of respiratory viruses, including COVID-19 strains.

Read Application Note
Rapid Detection of Respiratory Infections on Illumina MiniSeq System

Detection of respiratory viruses including coronavirus in <24 hours.

Read Application Note
Detect Respiratory Pathogens & Associated Resistance Genes

Rapid target enrichment workflow for broad detection of respiratory pathogens (including SARS-CoV-2 and flu viruses) and antimicrobial resistance genes.

Read Application Note

This pandemic has underscored the need for new tools to detect, diagnose, and monitor emerging pathogens like SARS-CoV-2. Together with the Illumina respiratory virus oligo probe (RVOP) enrichment panel, this customized Explify RVOP application from IDbyDNA provides a sample-to-result solution for clinical metagenomics.

View Webinar
Powering Clinical Metagenomics Analysis to Address SARS-CoV-2 Detection

The Explify Platform is a fully supported NGS-based, clinical metagenomics technology suite for clinical laboratories. Watch this video for a virtual tour to better understand how the Explify Platform streamlines processes, supports labs, improves results, and much, much more.

Watch Video
IDbyDNA's Explify Platform Delivers Advanced Insights

Featured Infectious Disease Articles

 
Illumina and IDbyDNA Partner to Deliver NGS Infectious Disease Solutions
Illumina and IDbyDNA Partner to Deliver NGS Infectious Disease Solutions

The partnership aims to accelerate and improve testing for emerging public health threats like SARS-Cov-2.

Read More
Next-Generation Sequencing Helps Fight Infectious Diseases Globally
Next-Generation Sequencing Helps Fight Infectious Diseases Globally

NGS technology enabled infectious disease experts to identify and characterize the genome of the novel coronavirus in China.

Read Review
How Sequencing-Based Surveillance Helps Fight COVID-19
How Sequencing-Based Surveillance Helps Fight COVID-19

Chief Medical Officer, Phil Febbo, MD, discusses how public officials follow the path of the epidemic and what that means for tracking the spread of coronavirus mutations.

Read More
Microbes and Metagenomics Research Review

This summary highlights recent peer-reviewed publications in which researchers used NGS to analyze viral populations, microbial pathogenesis, zoonotic reservoirs, the gut microbiome, and more.

Read Review
Microbes and Metagenomics Research Review

Genomic analysis with NGS provides high-resolution information to distinguish pathogen strains that differ by as little as one single-nucleotide polymorphism (SNP). It also allows identification of both novel and known infectious agents.

Illumina NGS technology delivers rapid results and high-quality data that public health professionals are utilizing to identify, track, and respond to infectious disease outbreaks.

Interested in receiving newsletters, case studies, and information on microbial genomics? Enter your email address.
Targeted Sequencing with the Pan-Viral Panel
Targeted Sequencing with the Pan-Viral Panel

This NGS workflow enables culture-free detection of viral targets without prior knowledge, even for mutagenic regions.

Read Application Note
Illumina NGS Virology Solutions
Virology NGS Solutions

Illumina NGS offers a comprehensive picture of viruses, host interactions, and phages specific to microbes.

Access PDF
Image
Influenza Surveillance in China

Learn how researchers at the Jiangsu CDC use Illumina NGS for influenza surveillance.

Read Article
Reconstructing Tuberculosis Outbreaks
Reconstructing Tuberculosis Outbreaks

NGS was used to reconstruct outbreaks of tuberculosis in British Columbia, Canada.

View Video
Deep Sequencing of HIV
Deep Sequencing of HIV

Learn about detection of drug resistance variants and tracking of viral haplotypes.

View Video
Diagnosing Infectious Disease with NGS
Diagnosing Infectious Disease with NGS

Dr Peyro-Saint-Paul explains how the CE-IVD marked iDTECT™ Blood Test can be used to detect pathogens in blood samples.

View Video
Image
HIV Variant Calling

Discover a streamlined workflow for HIV variant calling.

View Video
Detection of UTI Pathogens Tech Note
IDbyDNA Explify and NGS Identify UTI Pathogens

Accurate identification of uropathogens limits the development of UTIs and spread of antimicrobial resistance.

Access Tech Note